Stephanie Link always used to recommend this one on CNBC. It’s done nothing in two years.
J
Well good thing we had a good earnings.
J
bad news coming?
J
Bingo...there it is...GS downgrade to a sell.....after all these years I can't remember an out right sell. Dang.....
Y
bought like 30 years ago , spinoff etc ,.. Chinese company do better , needs new management
J
Looks like they are running for the hills. Bad news coming....again.
J
Well, forget about Bax for a year or so....unless new management arrives sooner.
A
5-star analyst Danielle Antalffy, of SVB Leerink, writes of Baxter, “[We] see BAX's underlying fundamentals -- accelerating sales growth, meaningful margin expansion -- as unchanged. One of the most meaningful datapoints in this quarter was 6% peritoneal dialysis patient growth… well ahead of the mid-single-digit long-term growth outlook for the Renal business that the Street is modeling. As the COVID pressures begin to lift, visibility into the long-term growth drivers should improve, and we would expect the shares to move meaningfully higher.”
And it doesn't hurt that Ray Dalio co-chief investment officer of the world's largest hedge fund, Bridgewater Associates just bought up 124,701 shares of the stock, a holding that is worth $9.73 million at current prices.
J
Well don't be surprised if something is wrong at the company....geez
C
Maybe if they started making batteries and losing money, the stock would skyrocket?
D
Holding on to BAX even though they have some accounting issues. Ultimately recoverable, I believe.
J
I added to my position today
D
2021 will be a great year for this company and due for a breakout given the strong fundamentals and an aging population.
T
I wonder what the investors who were unloading BAX today know that I don't? True, it's not terribly unusual to see a stock go down despite a solid earnings report; but it is VERY unusual to see that stock drop nearly 10% to a new 52-week low on huge volume.
C
REUTERS: Baxter International Inc. reported adjusted earnings of $501 million or $0.97 (vs $0.89 forecast) per share for the period. - Revenue: $3.04 billion in Q4 vs. $2.83 billion in the same period last year. -Guidance: Next quarter EPS guidance: $0.72 to $0.74
BAX is a safe heaven during this turmoil period. And the potential is relly good.
U
I believe next week BAX will surprise for the following Macroeconomic reasons:
1. Renal business pickup due to increase in hospitalization activities in urgent care category 2. Their consumable use in healthcare has gone up due to higher usage/disposal rate in healthcare 3. Non-covid healthcare activity increase over the last 6 month
J
Waiting for two things to happen!
1. Raise dividend...didn't happen 2. CEO resign....soon hopefully!
J
Well, tomorrow is the big day...fingers crossed.
J
Will be 85 within the week, cnbc said great company and best management in the business.
j
Why is Bax stock price keeps going down in spite of good fundamentals and very good potential post-covid with its products and services?
Dang.....
Bad news coming....again.
And it doesn't hurt that Ray Dalio co-chief investment officer of the world's largest hedge fund, Bridgewater Associates just bought up 124,701 shares of the stock, a holding that is worth $9.73 million at current prices.
BAX is a safe heaven during this turmoil period. And the potential is relly good.
1. Renal business pickup due to increase in hospitalization activities in urgent care category
2. Their consumable use in healthcare has gone up due to higher usage/disposal rate in healthcare
3. Non-covid healthcare activity increase over the last 6 month
1. Raise dividend...didn't happen
2. CEO resign....soon hopefully!